Caitlin Richardson

Pharmacist



  
  354 Santa Fe Dr, Encinitas
California, 92024-5142

 469-471-5817   
Caitlin Richardson is a pharmacist in Encinitas, California. Patients can reach her at 354 Santa Fe Dr, Encinitas or contact her on 469-471-5817. Active license number of Caitlin Richardson is 10528 for Pharmacist in California.
Caitlin Richardson is


Complete Profile:
Caitlin Richardson speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name: Caitlin Richardson
Specialization: Pharmacist
Gender:Female
Location:354 Santa Fe Dr, Encinitas,
California, 92024-5142
Phone:469-471-5817
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Caitlin Richardson are as mentioned below.
NPI Number: 1124935572
NPI Enumeration Date: 24 Aug, 2026
NPI Last Update On: 24 Aug, 2026

Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Caitlin Richardson are as mentioned below.
SpecializationLicense NumberStateStatus
Pharmacist 10528CaliforniaPrimary
70012CaliforniaSecondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 354 Santa Fe Dr,
Encinitas, California
Zip: 92024-5142
Phone Number: --
Patients can reach Caitlin Richardson at 354 Santa Fe Dr, Encinitas, California or can call on phone at 469-471-5817.

Comments/ Reviews:
Read all the reviews posted for Caitlin Richardson below. You may also share your own experience with Caitlin Richardson. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 September, 2026.